🕵️ ATEA Pharmaceuticals, Inc. ($AVIR)
SEC insider & ownership activity, last 12 months · CIK 1593899 · every row links its SEC filing
Over the last 12 months insiders bought $51K with no open-market selling against it. Polly A. Murphy bought $51K in discretionary trades (May–May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $51K (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Polly A. Murphy | 2 | $51K | 0 | – | May 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 15.0% | 13G | May 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 15.0% | 13G | May 6, 2026 | filing ↗ | |
| Jean-Pierre Sommadossi | 10.1% | 13G | May 14, 2025 | filing ↗ | |
| Leonard Braden Michael | 9.9% | 13G | Feb 9, 2026 | filing ↗ | |
| BML Investment Partners, L.P. | 9.6% | 13G | Feb 9, 2026 | filing ↗ | |
| Blackrock, Inc. | 7.1% | 13G | Apr 23, 2025 | filing ↗ | |
| JPM Partners LLC | 6.9% | 13G | May 14, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Earnings (2.02) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |